WASHINGTON – Neither snow nor tropical storms can stop officials at the FDA from speaking to physicians when given the chance. That was the scenario at the Transcatheter Cardiovascular Therapeutics symposium in September as the 10,000 attendees noticeably dwindled near the end of the meeting as Hurricane Isabel forced the District of Columbia to shutter its windows and doors.